[1]赵淑霞.TOAST分型rt-PA静脉溶栓治疗超早期脑梗死的效果研究[J].医学信息,2018,31(08):72-74.[doi:10.3969/j.issn.1006-1959.2018.08.022]
　ZHAO Shu-xia.Study on the Effect of Intravenous Thrombolytic Therapy with TOAST Type rt-PA in the Treatment of Super Early Cerebral Infarction[J].Journal of Medical Information,2018,31(08):72-74.[doi:10.3969/j.issn.1006-1959.2018.08.022]
点击复制

TOAST分型rt-PA静脉溶栓治疗超早期脑梗死的效果研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年08期
页码:
72-74
栏目:
论著
出版日期:
2018-04-15

文章信息/Info

Title:
Study on the Effect of Intravenous Thrombolytic Therapy with TOAST Type rt-PA in the Treatment of Super Early Cerebral Infarction
文章编号:
1006-1959（2018）08-0072-03
作者:
赵淑霞
天津静海区医院神经内科，天津 301600
Author(s):
ZHAO Shu-xia
Department of Neurology,Tianjin Jinghai District Hospital,Tianjin 301600,China
关键词:
TOAST分 型; 超早期脑梗死; rt-PA静脉溶栓; NIHSS评分
Keywords:
Key words：TOAST classification; Super early cerebral infarction; rt-PA intravenous thrombolysis; NIHSS score.
分类号:
R743
DOI:
10.3969/j.issn.1006-1959.2018.08.022
文献标志码:
A
摘要:
目的 评价超早期脑梗死TOAST分型rt-PA静脉溶栓治疗的有效性和安全性。方法 选取静海区医院收治的急性脑梗死患者129例，将所有脑梗死患者根据TOAST分型划分为LAA组、CE组、SAO组及SOE＋SUE组共四组，所选患者均为发病时间在4.5 h内，行规范性rt-PA静脉溶栓治疗，对比分析其临床效果和治疗的不良反应。结果 LAA组、CE组、SAO组、SOE＋SUE组溶栓治疗前后NIHSS评分下降，差异有统计学意义（P＜0.05）；溶栓治疗后各组NIHSS评分比较，SAO组低于LAA组、CE组、SOE＋SUE组，差异有统计学意义（P＜0.05）；CE组不良反应发生率高于LAA组、SAO组、SOE＋SUE组，差异有统计学意义（P＜0.05）。结论 超早期脑梗死4.5 h内行rt-PA静脉溶栓治疗不同TOAST分型脑梗死患者均可获益，且SAO型效果最佳；针对于CE患者应注意病情变化，降低其出血发生率。
Abstract:
Abstract：Objective To evaluate the efficacy and safety of TOAST classification rt-PA intravenous thrombolytic therapy for super early cerebral infarction.Methods 129 patients with acute cerebral infarction treated in Jinghai District Hospital were divided into four groups according to TOAST classification:LAA group,CE group,SAO group and SOE+SUE group.All the patients were treated with rt-PA intravenous thrombolytic therapy within 4.5 h.The clinical effect and adverse reaction of the treatment were compared and analyzed.Results The NIHSS scores of LAA group,CE group,SAO group,SOE+SUE group before and after thrombolytic therapy were significantly decreased,the difference was statistically significant(P<0.05);After thrombolytic treatment,the scores of NIHSS in group SAO were lower than that in group LAA,group CE and SOE+SUE group,the difference was statistically significant(P<0.05),and the incidence of adverse reactions in group CE was higher than that in group LAA,SAO and SOE+SUE group,and the difference was statistically significant(P<0.05).Conclusion The 4.5h rt-PA intravenous thrombolytic therapy in the ultra early cerebral infarction can benefit from the different TOAST type cerebral infarction patients,and the SAO type effect is the best.For the patients with CE,we should pay attention to the change of the disease and reduce the incidence of bleeding.

参考文献/References:

[1]朱海暴,杨静,沈永玲,等.轻型缺血性卒中TOAST分型及静脉溶栓的研究[J].中国医药导报,2017,14(23):56-59.
[2]李文武.急性脑梗死TOAST分型尿激酶静脉溶栓治疗198例临床疗效分析[J].大理学院学报,2017,2(4):41-45.
[3]李艳琴,王彦.TOAST分型脑梗死行rt-PA静脉溶栓疗效分析[C]//中国转化医学和整合医学研讨会.2015.
[4]石文芳.超急性期脑梗死患者低剂量rt-PA静脉溶栓临床观察[J].中国实用神经疾病杂志,2017,20(15):70-72.
[5]韩金玲,王传明,李巷,等.偏低剂量rt-PA静脉溶栓治疗不同分型超早期脑梗死的临床分析[J].中国生化药物杂志,2016(5):198-200.
[6]冯肖.rt-PA静脉溶栓在急性超早期脑梗死治疗中的应用研究[J].社区医学杂志,2016,14(3):70-71.
[7]陈华山,陈振云,熊海刚,等.瑞替普酶静脉溶栓治疗超早期脑梗死的疗效研究[J].现代实用医学,2015,27(8):1014-1016.
[8]杨琳,许宏伟.青年脑梗死TOAST各亚型患者预后及影响因素分析[J].实用医学杂志,2014(5):775-777.
[9]张莉,王莉.超早期急性脑梗死应用阿替普酶急诊静脉溶栓治疗的临床效果分析[J].中国继续医学教育,2014(5):106-107.
[10]曾昊,黄镪,武剑,等.二级医院与三级医院应用阿替普酶静脉溶栓治疗急性脑梗死安全性及疗效的比较[J].中国脑血管病杂志,2014(7):359-363.
[11]廖晓凌,王伊龙,潘岳松,等.急性缺血性卒中不同剂量阿替普酶静脉溶栓疗效比较[J].中国卒中杂志,2014,9(7):551-556.
[12]王开.rt-PA在84例急性脑梗死患者早期静脉溶栓治疗中的应用[J].内蒙古中医药,2013,32(2):83-83.
[13]张超,谢炳玓.脑梗死TOAST分型与同型半胱氨酸和NIHSS评分的关系[J].广东医学,2011,32(18):2443-2445.

更新日期/Last Update: 2018-04-15